Inborn errors resulting in isolated functional methionine synthase def
iciency fall into two complementation groups, cblG and cblE. Using bio
chemical approaches we demonstrate that one cblG patient has greatly r
educed levels of methionine synthase while in another, the enzyme is s
pecifically impaired in the reductive activation cycle, The biochemica
l data suggested that low levels of methionine synthase activity in th
e first patient may result from mutations in the catalytic domains of
the enzyme, reduced transcription, or generation of unstable message o
r protein, Using Northern analysis, we demonstrate that the molecular
basis for the biochemical phenotype in this patient is associated with
greatly diminished steady-state levels of methionine synthase mRNA, T
he biochemical data on the second patient cell line implicated mutatio
ns specific to reductive activation, a function that is housed in the
C-terminal AdoMet-binding domain and the intermediate B-12-binding dom
ain, in the highly homologous bacterial enzyme, We have detected two m
utations in a compound heterozygous state, one that results in convers
ion of a conserved proline (1173) to a leucine residue and the other a
deletion of an isoleucine residue (881), The crystal structure of the
C-terminal domain of the Escherichia coli MS predicts that the Pro to
Leu mutation could disrupt activation since it is embedded in a seque
nce that makes direct contacts with the bound AdoMet, Deletion of isol
eucine in the B-12-binding domain would result in shortening of a beta
-sheet, Our data provide the first evidence for mutations in the methi
onine synthase gene being culpable for the cblG phenotype. In addition
, they suggest directly that mutations in methionine synthase can lead
to elevated homocysteine, implicated both in neural tube defects and
in cardiovascular diseases.